Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul-Sep;15(3):249-255.
doi: 10.4103/UA.UA_170_20. Epub 2023 Jul 17.

Traditional and novel imaging modalities for advanced prostate cancer: A critical review

Spencer Hill  1 , Farzaan Kassam  1 , Sadhna Verma  1 , Abhinav Sidana  1
Affiliations
Review

Traditional and novel imaging modalities for advanced prostate cancer: A critical review

Spencer Hill et al. Urol Ann. 2023 Jul-Sep.

Abstract

Accurate detection of metastatic prostate cancer in the setting of preoperative staging as well as posttreatment recurrence is crucial to provide patients with appropriate and timely treatment of their disease. This has traditionally been accomplished with a combination of computed tomography, magnetic resonance imaging, and bone scan. Recently, more novel imaging techniques have been developed to help improve the detection of advanced and metastatic prostate cancer. This review discusses the efficacy of the traditional imaging modalities as well as the novel imaging techniques in detecting metastatic prostate cancer. Articles discussed were gathered through a formal PubMed search.

Keywords: Imaging; metastatic; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Pt. is 66-year-old male with a history of Gleason 4+3 prostate cancer s/p = status post radical prostatectomy in 2013 followed by salvage radiation therapy. Patient presented with rising prostate-specific antigen and underwent Fluciclovine positron emission tomography scan for restaging. Imaging demonstrates abnormal Fluciclovine uptake involving R external lymph node, consistent with metastasis. Patient underwent salvage LN dissection and pathology of metastasis was confirmed. (b) Patient is 66-year-old male with a history of Gleason 4+3 prostate cancer s/p radical prostatectomy in 2013 followed by salvage radiation therapy. Patient presented with rising prostate-specific antigen and underwent Fluciclovine positron emission tomography scan for restaging. Subtle increased uptake in R aspect of sacrum, representing possible early bone metastases
See this image and copyright information in PMC

References

    1. Street W. American Cancer Society. Cancer Facts and Figures 2020. Atlanta: American Cancer Society; 2020.
    1. Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer:A review. JAMA. 2017;317:2532–42. - PubMed
    1. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591–7. - PubMed
    1. Tourinho-Barbosa R, Srougi V, Nunes-Silva I, Baghdadi M, Rembeyo G, Eiffel SS, et al. Biochemical recurrence after radical prostatectomy:What does it mean? Int Braz J Urol. 2018;44:14–21. - PMC - PubMed
    1. National Comprehensive Cancer Network. Prostate Cancer (version 1.2018. 2018. [Last accessed on 2020 Sep 20]. Available from:https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf .